Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Heerde

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|October 10, 1998
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a reviewR Fonseca, M Yamakawa, S Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's diseaseF E van Leeuwen, R Somers, B G Taal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1991
Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphomaJ G Letschert, D González González, J Oskam, et al.
Histopathology|December 1, 1993
Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical courseP C De Bruin, N M Jiwa, P Van der Valk, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751)C De Wolf-Peeters, B Caillou, J Diebold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Second cancer risk following Hodgkin's disease: a 20-year follow-up studyF E van Leeuwen, W J Klokman, A Hagenbeek, et al.
The Journal of Pathology|November 1, 1992
High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomasP Kanavaros, N M Jiwa, P C de Bruin, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 1998
Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?A A Brink, J J Oudejans, A J van den Brule, et al.
Histopathology|August 1, 1995
Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 casesJ Van Gorp, P C De Bruin, D M Sie-Go, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|October 10, 1998
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a reviewR Fonseca, M Yamakawa, S Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's diseaseF E van Leeuwen, R Somers, B G Taal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1991
Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphomaJ G Letschert, D González González, J Oskam, et al.
Histopathology|December 1, 1993
Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical courseP C De Bruin, N M Jiwa, P Van der Valk, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751)C De Wolf-Peeters, B Caillou, J Diebold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Second cancer risk following Hodgkin's disease: a 20-year follow-up studyF E van Leeuwen, W J Klokman, A Hagenbeek, et al.
The Journal of Pathology|November 1, 1992
High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomasP Kanavaros, N M Jiwa, P C de Bruin, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 1998
Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?A A Brink, J J Oudejans, A J van den Brule, et al.
Histopathology|August 1, 1995
Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 casesJ Van Gorp, P C De Bruin, D M Sie-Go, et al.
Pageof 7